Lucy Scientific Discovery Announces Proposal to Acquire Pasithea Therapeutics Corp.
VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (“Lucy” or “the Company”) (NASDAQ: LSDI), a...
Mental Health
Beckley Waves Establishes Ethics Council to Guide Industry Standards and Best Practices During Inaugural Summit of The World’s Leaders in Psychedelics
The New Ethics Council will Work Alongside Beckley Waves to set the Standard for Sustainable and Ethical Operations in the...
Solera Launches Streamlined Multi-Condition Management Platform for Employers to Increase Accountability While Reducing Costs
With Solera’s curated network of algorithmically matched digital health solutions, employers can reduce administrative burden and costs with a single...
COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference
LONDON, May 26, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating...
Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan
Lower Medication Requirement Helps Depression Patients Obtain Treatment SoonerMALVERN, Pa., May 26, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM),...
Sunstone Therapies presents data at ASCO showing positive long-term follow-up results from psilocybin therapy in cancer patients with major depressive disorder (MDD)
Sunstone Therapies presents data at ASCO showing positive long-term follow-up results from psilocybin therapy in cancer patients with major depressive...
Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023
More than half of the patients demonstrated remission of depression at 18 months, after a single dose of 25mg investigational...
New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction
Lowest satisfaction among medication users, highest for users of non-drug solution TMS Therapy NeuroStar Depression Barometer Infographic FocalData survey results...
BrainsWay Announces Appointment of Ido Marom as CFO
BURLINGTON, Mass. and JERUSALEM, May 23, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Lucy Scientific Discovery Inc.’s Functional Amanita Line Now Available for Purchase through Retail Channels
VANCOUVER, British Columbia, May 22, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a leader in natural and...
Lucy Scientific Discovery Inc. Announces Sponsorship at the Psychedelic Science Conference June 19-25, 2023
VANCOUVER, British Columbia, May 19, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (“Lucy” or “the Company”) (NASDAQ: LSDI), a...
Lucy Scientific Discovery Inc. Accelerates Psilocybin Access and Product Launch through a Strategic Partnership with TheraPsil
VANCOUVER, British Columbia, May 18, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (“Lucy” or “the Company”) (NASDAQ: LSDI), a...
Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market
Upon completion of validated regulatory and clinical documentation, the GMP extracted product will be exported to Australia in preparation for...
BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights
BURLINGTON, Mass. and JERUSALEM, May 17, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Neuronetics Wins 2023 Bell Seal for Workplace Mental Health
The Company is recognized for its commitment to employees’ well-beingMALVERN, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:...
Join the Ride for Youth Mental Health: Help Make an Impact on Young Lives Today!
Canadian charity Jack.org and its supporters unite to raise funds that provide young people with the mental health education and...
Stella Opens Flagship PTSD Treatment Location in Chicago and Secures $7M in Funding
Funds raised from Sterling Partners will be used to further innovative research and expand access to cutting-edge careCHICAGO, May 09,...
Neuronetics Reports Record First Quarter 2023 Financial and Operating Results
MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology...
Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR
Achievement demonstrates Company’s commitment to rigorous standards for safe and effective productsMALVERN, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- Neuronetics,...
Clearmind Medicine Strengthens Scientific Advisory Board with Appointment of Prof. Joseph Tam
Hebrew University of Jerusalem professor is an expert on obesity and metabolic syndrome Tel Aviv, Israel / Vancouver, Canada, May...